Peripheral visual field loss following treatment with etanercept
| Autor: | L J Clifford, J D Rossiter |
|---|---|
| Rok vydání: | 2004 |
| Předmět: |
musculoskeletal diseases
medicine.medical_specialty Letter business.industry medicine.disease Sensory Systems Etanercept Peripheral Visual field Surgery Cellular and Molecular Neuroscience Ophthalmology Rheumatoid arthritis medicine Peripheral visual field loss Etanercept therapy skin and connective tissue diseases business Uveitis medicine.drug |
| Zdroj: | British Journal of Ophthalmology. 88:842-842 |
| ISSN: | 0007-1161 |
| DOI: | 10.1136/bjo.2003.036954 |
| Popis: | Etanercept is a relatively new anti-tumour necrosis factor α (TNF-α) therapy for inflammatory arthritides. Although there may be an association with uveitis,1 there have been no reports of patients experiencing visual disturbance.2 We present a case of a patient who developed symptomatic bilateral peripheral visual field loss shortly after initiation of treatment with etanercept. A 59 year old woman was referred complaining of bilateral, sequential peripheral visual field disturbance, which developed during a course of etanercept therapy for rheumatoid arthritis. Initially she noticed a left upper temporal field defect occurring the day after receiving the first injection of etanercept. Following the second injection she became aware of … |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|